The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Ever Valinject competitive analysis

Loading summary...

Explore patent oppositions filed by Ever Valinject against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3324937	Ready-To-Use Bortezomib Solution	STADA ARZNEIMITTEL	Aug 18, 2022
EP3222272	Pharmaceutical Composition	FERRING	Aug 1, 2022
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 22, 2021
EP2493466	Novel Antitumoral Use Of Cabazitaxel	AVENTIS PHARMA	Mar 12, 2021

Discover the latest PTAB cases involving Ever Valinject, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Ever Valinject with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
EVER VALINJECT	4	-	-	-
AVENTIS PHARMA	-	24	-	3
FERRING	5	10	-	-
JANSSEN PHARMACEUTICA	1	59	-	1